Kevin Lee is CHIEF EXECUTIVE OFFICER of BICYCLE THERAPEUTICS plc. Currently has a direct ownership of 380,864 shares of BCYC, which is worth approximately $7.75 Million. The most recent transaction as insider was on Jul 23, 2021, when has been sold 4,782 shares (Ordinary Shares) at a price of $14.0 per share, resulting in proceeds of $66,948. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 381K
0.84% 3M change
18.23% 12M change
Total Value Held $7.75 Million

Kevin Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 23 2021
BUY
Exercise of conversion of derivative security
$66,948 $14.0 p/Share
4,782 Added 1.88%
249,867 Ordinary Shares
Jul 16 2021
SELL
Open market or private sale
$20,706 $34.0 p/Share
609 Reduced 0.25%
245,085 Ordinary Shares
Jul 16 2021
BUY
Exercise of conversion of derivative security
$8,526 $14.0 p/Share
609 Added 0.25%
245,694 Ordinary Shares
Jul 15 2021
SELL
Open market or private sale
$753,132 $34.28 p/Share
21,970 Reduced 8.23%
245,085 Ordinary Shares
Jul 15 2021
BUY
Exercise of conversion of derivative security
$307,580 $14.0 p/Share
21,970 Added 7.6%
267,055 Ordinary Shares
Jul 14 2021
SELL
Open market or private sale
$494,848 $34.21 p/Share
14,465 Reduced 5.57%
245,085 Ordinary Shares
Jul 14 2021
BUY
Exercise of conversion of derivative security
$116,634 $14.0 p/Share
8,331 Added 3.11%
259,550 Ordinary Shares
Jul 13 2021
SELL
Open market or private sale
$1,292,336 $33.17 p/Share
38,961 Reduced 13.43%
251,219 Ordinary Shares
Jul 13 2021
BUY
Exercise of conversion of derivative security
$496,244 $14.0 p/Share
35,446 Added 10.89%
290,180 Ordinary Shares
Jul 12 2021
SELL
Open market or private sale
$62,029 $32.04 p/Share
1,936 Reduced 0.75%
254,734 Ordinary Shares
Jul 12 2021
BUY
Exercise of conversion of derivative security
$27,104 $14.0 p/Share
1,936 Added 0.75%
256,670 Ordinary Shares
May 07 2021
SELL
Open market or private sale
$180,617 $32.23 p/Share
5,604 Reduced 2.15%
254,734 Ordinary Shares
May 07 2021
BUY
Exercise of conversion of derivative security
$78,456 $14.0 p/Share
5,604 Added 2.11%
260,338 Ordinary Shares
May 06 2021
SELL
Open market or private sale
$55,152 $32.14 p/Share
1,716 Reduced 0.67%
254,734 Ordinary Shares
May 06 2021
BUY
Exercise of conversion of derivative security
$24,024 $14.0 p/Share
1,716 Added 0.66%
256,450 Ordinary Shares
May 04 2021
SELL
Open market or private sale
$28,731 $32.03 p/Share
897 Reduced 0.35%
254,734 Ordinary Shares
May 04 2021
BUY
Exercise of conversion of derivative security
$12,558 $14.0 p/Share
897 Added 0.35%
255,631 Ordinary Shares
May 03 2021
SELL
Open market or private sale
$109,055 $32.16 p/Share
3,391 Reduced 1.31%
254,734 Ordinary Shares
May 03 2021
BUY
Exercise of conversion of derivative security
$47,474 $14.0 p/Share
3,391 Added 1.3%
258,125 Ordinary Shares
Apr 30 2021
SELL
Open market or private sale
$923,734 $30.38 p/Share
30,406 Reduced 10.66%
254,734 Ordinary Shares
Apr 30 2021
BUY
Exercise of conversion of derivative security
$425,684 $14.0 p/Share
30,406 Added 9.64%
285,140 Ordinary Shares
Apr 29 2021
SELL
Open market or private sale
$184,452 $30.65 p/Share
6,018 Reduced 2.31%
254,734 Ordinary Shares
Apr 29 2021
BUY
Exercise of conversion of derivative security
$84,252 $14.0 p/Share
6,018 Added 2.26%
260,752 Ordinary Shares
Apr 28 2021
SELL
Open market or private sale
$715,791 $31.82 p/Share
22,495 Reduced 8.11%
254,734 Ordinary Shares
Apr 28 2021
BUY
Exercise of conversion of derivative security
$314,930 $14.0 p/Share
22,495 Added 7.51%
277,229 Ordinary Shares
KL

Kevin Lee

CHIEF EXECUTIVE OFFICER
Cambridge, X0

Track Institutional and Insider Activities on BCYC

Follow BICYCLE THERAPEUTICS plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCYC shares.

Notify only if

Insider Trading

Get notified when an Bicycle Therapeutics PLC insider buys or sells BCYC shares.

Notify only if

News

Receive news related to BICYCLE THERAPEUTICS plc

Track Activities on BCYC